New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Celldex Therapeutics, Inc.
CLDX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 24 Feb 2025

2B

Biotechnology

Next Earning date - 24 Feb 2025

24.20USD

Shape1.05 ( 4.54%)
Market Closed (as of Feb 05, 17:51 EDT)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

-66%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated February 7, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

CLDX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

Shape20%

2025-Revenue

$3.28

Shape-413%

2025-EPS

$4M

Shape93%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2024-10-07

Now: Buy

Goldman Sachs

initialise

Previous: Not converted

2024-09-30

Now: Neutral

Leerink Partners

downgrade

Previous: Not converted

2024-09-27

Now: Market Perform

Wolfe Research

downgrade

Previous: Buy

2024-09-26

Now: Peer Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.56
vs -0.43

Q1.23

arrow
arrow

N/A

-0.62
vs -0.49

Q2.23

arrow
arrow

N/A

-0.65
vs -0.58

Q3.23

arrow
arrow

N/A

-0.81
vs -0.57

Q4.23

arrow
arrow

N/A

-0.57
vs -0.56

Q1.24

arrow
arrow

N/A

-0.56
vs -0.62

Q2.24

arrow
arrow

N/A

-0.54
vs -0.65

Q3.24

arrow
arrow

N/A

-0.64
vs -0.81

Q4.24

arrow
arrow

N/A

-0.74
vs -0.57

Q1.25

arrow
arrow

N/A

-0.80
vs -0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+384%

1.6M  vs 333K

Q1.23

arrow
arrow

+456%

967K  vs 174K

Q2.23

arrow
arrow

+64%

268K  vs 163K

Q3.23

arrow
arrow

+273%

1.5M  vs 407K

Q4.23

arrow
arrow

+156%

4.1M  vs 1.6M

Q1.24

arrow
arrow

-84%

156K  vs 967K

Q2.24

arrow
arrow

+832%

2.5M  vs 268K

Q3.24

arrow
arrow

+110%

3.2M  vs 1.5M

Q4.24

arrow
arrow

-75%

1M  vs 4.1M

Q1.25

arrow
arrow

+188%

450K  vs 156K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-7%

-0.07
vs -0.08

Q1.23

arrow
arrow

-7%

-0.07
vs -0.07

Q2.23

arrow
arrow

-11%

-0.11
vs -0.07

Q3.23

arrow
arrow

-16%

-0.16
vs -0.11

Q4.23

arrow
arrow

-10%

-0.10
vs -0.16

Q1.24

arrow
arrow

-4%

-0.04
vs -0.10

Q2.24

arrow
arrow

-4%

-0.04
vs -0.04

Q3.24

arrow
arrow

-5%

-0.05
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

182

182
vs 161

13%

Q1.23

arrow
arrow

169

169
vs 182

-7%

Q2.23

arrow
arrow

161

161
vs 169

-5%

Q3.23

arrow
arrow

158

158
vs 161

-2%

Q4.23

arrow
arrow

177

177
vs 158

12%

Q1.24

arrow
arrow

204

204
vs 177

15%

Q2.24

arrow
arrow

188

188
vs 204

-8%

Q3.24

arrow
arrow

199

199
vs 188

6%

Earnings Growth

Latest News